Jyong Biotech Ltd.

US$1.80As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MENSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (95.98%)
Mkt cap US$133.6M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.82
1.36%
(82.16%)
Hold 6|9|9|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.03
15.11%
12.08%
24.95%
22.42%
Revenue$M
6.727
6.729
6.929
7.290
3.79%
5.61%
3.81%
8.39%
Peers (US$133.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.840
(0.396)
(0.398)
EBIT/Intx
0.522
0.159
0.176
Own earn%
77.33
(265.12)
(177.52)
Sh yield%
55.75
33.09
30.22
Owners
Insiders/Inst%
2.93
56.96
Short interest%
5.64
SBC / revenue%
0.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
10–20
$1 testx
0.0
Incr. ROIC%
4